World News: 14:00 GMT Thursday 6th December 2018. [Client Outlook via Globe Newswire via SPi World News]
WATERLOO, Ontario, Dec. 06, 2018 (GLOBE NEWSWIRE) -- , a leading provider of FDA Class II clinical and diagnostic image viewing solutions, announced today its partnership with to support the use of medical imaging in clinical trials.
The Medidata Cloud is the most used unified platform in life sciences for clinical development, commercial, and real-world data. Powered by artificial intelligence, the Intelligent Platform for Life Sciences helps pharmaceutical, biotech, medical device companies and academic researchers accelerate value, minimize risk and optimize outcomes.
The use of medical imaging data as an endpoint in clinical trials is becoming increasingly important due to its critical role in determining disease state and progression, especially in therapeutic areas like oncology where nearly all trials rely on imaging. Medidata selected eUnity™ to help manage medical images based on its HTML5-based zero-footprint architecture which demonstrated superior ability to tightly integrate with the Medidata Cloud.
eUnity is the industry’s first Smartviewer; an adaptable zero-footprint software platform that combines advanced image viewing and integration capabilities. Its progressive architecture facilitates interoperability with diverse technologies, while powerful hanging protocols and MIP/MPR/3D advanced visualization functionality meet the performance demands for diagnostic radiology reading and breast imaging. eUnity requires no specialized hardware and needs only minimal resources to deploy, making it an ideal solution for a cloud platform.
“The use of medical imaging in clinical trials continues to expand and our partners and sponsors need powerful image viewing capabilities to manage and assess images at any point in a clinical trial,” said Dan Braga, Senior Director of Medical Imaging at Medidata. “eUnity was a natural choice to plug into our platform due to its zero-footprint architecture, powerful image assessment tools, and measurement export capabilities.”
“The parallels between Client Outlook and Medidata make for a perfect union,” said Steve Rankin, President and CEO, Client Outlook. “We both specialize in what we do – using a single platform design approach to develop highly adaptable solutions that improve productivity and deliver appreciable clinical value.” Rankin added; “We are thrilled to partner with Medidata in the life sciences sector to show our breadth and scalability in a new market area that has such an important social impact.”
John MarshallVice President, Sales and Marketing, Client Outlook315-278-0023
Globe Newswire: 14:00 GMT Thursday 6th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.